Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00376857|
Recruitment Status : Completed
First Posted : September 15, 2006
Last Update Posted : September 15, 2006
|Condition or disease||Intervention/treatment||Phase|
|Idiopathic Epiretinal Membrane, Cataract||Drug: Surgery with and without the aid of Indocyanine Green (ICG)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green: a Randomised Controlled Clinical Trial|
- The main outcome measure was improvement of best-corrected visual acuity (BCVA).
- Other outcome measures included postoperative BCVA, status of Amsler grid test, reduction of macular retinal thickness, residual or recurrent macular epiretinal membrane
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00376857
|Dept. of Ophthalmology, University of Regensburg|
|Regensburg, Germany, 93042|
|Principal Investigator:||Jost Hillenkamp, MD||Dept. of Ophthalmology, University of Regensburg|
|Principal Investigator:||Parykshit Saikia, MD||Dept. of Ophthalmology, University of Regensburg|
|Study Chair:||Helmut G Sachs, MD||Dept. of Ophthalmology, University of Regensburg|